文献速递生殖医学妇科

干细胞分泌因子疗法再生卵巢微环境并挽救卵泡

Stem cell-secreted factor therapy regenerates the ovarian niche and rescues follicles.
PubMed 文献 · Am J Obstet Gynecol · 2021-02-01

该研究在小鼠化疗卵巢损伤模型中评估了富含骨髓干细胞可溶性因子的血浆、脐带血血浆及其激活形式对卵巢微环境和卵泡发育的作用,并在人卵巢皮质异种移植模型中验证了最有效血浆。结果显示激活的粒细胞集落刺激因子动员血浆恢复效果最强,可促进血管形成、细胞增殖并减少凋亡,从而挽救卵泡发育和生育力。

要点

  • 激活的G-CSF动员血浆在动物和人卵巢组织中恢复效果最强
  • 干细胞分泌因子血浆可促进卵巢血管形成、细胞增殖并减少凋亡
  • 该疗法有望改善卵巢功能受损女性的生殖结局

核心结论

  • 富含干细胞分泌因子的G-CSF动员血浆和脐带血血浆可有效改善卵巢功能受损女性的生殖结局。
  • 激活的G-CSF血浆因同时富含干细胞分泌因子和血小板内生长因子且可自体来源,似为最有前景的治疗。

研究设计与样本

  • 第一阶段在小鼠化疗诱导卵巢损伤模型(每组n=7)中评估血浆对卵巢微环境、卵泡发育和生育性能的影响,并分析血浆蛋白质组。
  • 第二阶段在人卵巢皮质异种移植免疫缺陷小鼠模型(每组n=4)中验证最有效的血浆治疗。

主要发现

  • 输注G-CSF动员的骨髓干细胞可溶性因子富集血浆或脐带血血浆可诱导不同程度的微血管形成和细胞增殖,并减少卵巢组织凋亡,从而挽救卵泡发育和生育力。
  • 血浆激活增强了上述效应。
  • 激活的G-CSF血浆在小鼠和人卵巢中诱导的卵巢挽救作用最强。
  • 蛋白质组分析提示其效应可能由与细胞周期和凋亡、基因表达、信号转导、细胞通讯、应激反应及双链断裂DNA修复相关的可溶性因子介导。

临床怎么用

  • 干细胞分泌因子血浆,尤其是激活的G-CSF动员血浆,可能成为改善卵巢功能受损女性生殖结局的治疗选择。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Ovarian senescence is a normal age-associated phenomenon, but increasingly younger women are affected by diminished ovarian reserves or premature ovarian insufficiency. There is an urgent need for developing therapies to improve ovarian function in these patients. In this context, previous studies suggest that stem cell-secreted factors could have regenerative properties in the ovaries. OBJECTIVE: This study aimed to test the ability of various human plasma sources, enriched in stem cell-secreted factors, and the mechanisms behind their regenerative properties, to repair ovarian damage and to promote follicular development. STUDY DESIGN: In the first phase, the effects of human plasma enriched in bone marrow stem cell soluble factors by granulocyte colony-stimulating factor mobilization, umbilical cord blood plasma, and their activated forms on ovarian niche, follicle development, and breeding performance were assessed in mouse models of chemotherapy-induced ovarian damage (n=7 per group). In addition, the proteomic profile of each plasma was analyzed to find putative proteins and mechanism involved in their regenerative properties in ovarian tissue. In the second phase, the most effective plasma treatment was validated in human ovarian cortex xenografted in immunodeficient mice (n=4 per group). RESULTS: Infusion of human plasma enriched bone marrow stem cell soluble factors by granulocyte colony-stimulating factor mobilization or of umbilical cord blood plasma-induced varying degrees of microvessel formation and cell proliferation and reduced apoptosis in ovarian tissue to rescue follicular development and fertility in mouse models of ovarian damage. Plasma activation enhanced these effects. Activated granulocyte colony-stimulating factor plasma was the most potent inducing ovarian rescue in both mice and human ovaries, and proteomic analysis indicated that its effects may be mediated by soluble factors related to cell cycle and apoptosis, gene expression, signal transduction, cell communication, response to stress, and DNA repair of double-strand breaks, the most common form of age-induced damage in oocytes. CONCLUSION: Our findings suggested that stem cell-secreted factors present in both granulocyte colony-stimulating factor-mobilized and umbilical cord blood plasma could be an effective treatment for increasing the reproductive outcomes in women with impaired ovarian function owing to several causes. The activated granulocyte colony-stimulating factor plasma, which is already enriched in both stem cell-secreted factors and platelet-enclosed growth factors, seems to be the most promising treatment because of its most potent restorative effects on the ovary together with the autologous source.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Buigues A, Marchante M, de Miguel-Gómez L, et al. Stem cell-secreted factor therapy regenerates the ovarian niche and rescues follicles. Am J Obstet Gynecol. 2021. PMID: 33539826. doi:10.1016/j.ajog.2021.01.023

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。